Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Harvard Business School
US Army
Covington
Daiichi Sankyo
UBS
Julphar
Mallinckrodt

Generated: July 17, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ibrutinib

« Back to Dashboard

ibrutinib

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC N 57962-070-28
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC N 57962-140-09
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC N 57962-140-12
Pharmacyclics Inc IMBRUVICA ibrutinib TABLET;ORAL 210563 NDA Pharmacyclics LLC N 57962-014-28
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Healthtrust
AstraZeneca
Deloitte
Medtronic
Covington
Johnson and Johnson
Cerilliant
Chinese Patent Office